Abstract
A series of chromene fused cytosine and uracil were prepared by the condensation of thiourea or carbon disulphide with 2-amino-7,7-dimethyl-5-oxo-4-(substituted phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile. The newly synthesized compounds were characterized by IR, 1H-NMR, Elemental analysis and some representative 13C-NMR and Mass spectra. All the title compounds were evaluated for antitubercular and antimicrobial activities against various mycobacterial, bacterial and fungal strains. Some of the compounds have shown promising antimicrobial and antitubercular activity while others were inactive.
Keywords: Antimicrobial activity, antitubercular activity, chromene, fused cytosine, fused uracil.
Anti-Infective Agents
Title:Design, Synthesis and In Vitro Anti-Mycobacterial Activity of Chromene Fused Cytosine and Uracil Analogues
Volume: 11 Issue: 1
Author(s): Nimesh R. Kamdar, Dhaval D. Haveliwala, Prashant T. Mistry and Saurabh K. Patel
Affiliation:
Keywords: Antimicrobial activity, antitubercular activity, chromene, fused cytosine, fused uracil.
Abstract: A series of chromene fused cytosine and uracil were prepared by the condensation of thiourea or carbon disulphide with 2-amino-7,7-dimethyl-5-oxo-4-(substituted phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile. The newly synthesized compounds were characterized by IR, 1H-NMR, Elemental analysis and some representative 13C-NMR and Mass spectra. All the title compounds were evaluated for antitubercular and antimicrobial activities against various mycobacterial, bacterial and fungal strains. Some of the compounds have shown promising antimicrobial and antitubercular activity while others were inactive.
Export Options
About this article
Cite this article as:
Kamdar R. Nimesh, Haveliwala D. Dhaval, Mistry T. Prashant and Patel K. Saurabh, Design, Synthesis and In Vitro Anti-Mycobacterial Activity of Chromene Fused Cytosine and Uracil Analogues, Anti-Infective Agents 2013; 11 (1) . https://dx.doi.org/10.2174/22113626130105
DOI https://dx.doi.org/10.2174/22113626130105 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies for Developing Tuberculosis Vaccines: Emerging Approaches
Current Drug Targets In-vitro Functionality of Clozapine Biphasic Release Minitablet Using Advanced Statistical Tools
Drug Delivery Letters Interstitial Lung Disease Associated with Collagen Vascular Disease
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Synthesis, Antitrypanosomal and Antimycobacterial Activities of Coumarin N-acylhydrazonic Derivatives
Medicinal Chemistry Adjunctive Immunotherapeutic Efficacy of N-Formylated Internal Peptide of Mycobacterial Glutamine Synthetase in Mouse Model of Tuberculosis
Protein & Peptide Letters Progress on the Discovery of Inhibitors of InhA, the FAS II Enoyl-ACP Reductase TB Drug Discovery Targeted on InhA
Letters in Drug Design & Discovery Comparison of Large Proteomic Datasets
Current Proteomics In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT)
Infectious Disorders - Drug Targets Antimicrobial Evaluation of 5-Substituted Aryl 1H-Tetrazoles
Medicinal Chemistry Immunomodulatory Activity of Garlic
Current Immunology Reviews (Discontinued) Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control
Current Drug Delivery Computational Evidence for the Reactivation Process of Human Acetylcholinesterase Inhibited by Carbamates
Combinatorial Chemistry & High Throughput Screening Aqua Mediated Synthesis of Bio-active Compounds
Mini-Reviews in Medicinal Chemistry Health Benefits of Ipecac and Cephaeline: their Potential in Health Promotion and Disease Prevention
Current Bioactive Compounds Patent Selection
Recent Patents on Biotechnology Progress in Structure-Based Design of EGFR Inhibitors
Current Drug Targets Applications of Polymeric Nanocapsules in Field of Drug Delivery Systems
Current Drug Discovery Technologies Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants
Anti-Infective Agents Structure-Based Drug Discovery Accelerated by Many-Core Devices
Current Drug Targets Pharmaceutical Care: Past, Present and Future
Current Pharmaceutical Design